Zomedica Announces 2019 Annual Meeting Results
05 nov. 2019 16h15 HE
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., Nov. 05, 2019 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (TSX-V:ZOM) (“Zomedica” or “Company”), a veterinary pharmaceutical and health care solutions company, is pleased to...
Zomedica Commences Final TRUFORMA™ Diagnostic Verification Study
31 oct. 2019 06h55 HE
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., Oct. 31, 2019 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) (TSX-V: ZOM), a veterinary diagnostic and pharmaceutical company, announced today that it has...
Zomedica names Dr. Stephanie Morley President
17 sept. 2019 06h55 HE
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., Sept. 17, 2019 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) (TSX-V: ZOM), a veterinary diagnostic and pharmaceutical company, today announced that Dr....
Zomedica to Present at RHK Capital 2019 Disruptive Growth Conference, Fall Investor Summit, and Sidoti & Company Fall 2019 Investor Conference
03 sept. 2019 06h55 HE
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., Sept. 03, 2019 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) (TSX-V: ZOM), a veterinary diagnostic and pharmaceutical company, today announced that it...
Animal Health Veteran Johnny D. Powers Joins Zomedica Board of Directors
19 août 2019 06h55 HE
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., Aug. 19, 2019 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American:ZOM) (TSX-V:ZOM) (“Zomedica” or the “Company”), a veterinary diagnostic and pharmaceutical...
Zomedica Announces Second Quarter 2019 Financial Results
08 août 2019 16h08 HE
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., Aug. 08, 2019 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American:ZOM) (TSX-V:ZOM) (“Zomedica” or “Company”), a veterinary diagnostic and pharmaceutical company,...
Zomedica Announces TRUFORMA™ Assay Updates and R&D Expansion
07 août 2019 06h55 HE
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., Aug. 07, 2019 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) (TSX-V: ZOM), a veterinary diagnostic and pharmaceutical company, today announced additional...
Zomedica Announces Completion of Initial Development of a Lymphoma Assay for its Canine Cancer Liquid Biopsy Platform
13 juin 2019 06h55 HE
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., June 13, 2019 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) (TSX-V: ZOM), a veterinary diagnostic and pharmaceutical company, today announced that it has...
Zomedica to Present at Raymond James Life Sciences and MedTech Conference
12 juin 2019 16h35 HE
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., June 12, 2019 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) (TSX-V: ZOM), a veterinary diagnostic and pharmaceutical company, today announced that it will...
Zomedica Announces $7 Million Second Tranche Closing of Preferred Shares
10 juin 2019 06h00 HE
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., June 10, 2019 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) (TSX-V: ZOM) (“Zomedica” or “Company”), a veterinary diagnostic and pharmaceutical company,...